| Financial Year |
March 31 2023 |
| Monetary Funds |
909,373,468.00 |
| Held-for-trading Financial Assets |
30,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
197,996,621.72 |
| Advances to Suppliers |
3,794,432.11 |
| Other Receivables |
1,568,071.47 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
5,192,462.78 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
-- |
| Total Current Assets |
1,276,394,903.89 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
6,822,620.02 |
| Investment Properties |
5,353,627.08 |
| Fixed Assetes |
44,714,323.04 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
25,719,960.82 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,547,449.36 |
| Deferred Income Tax Assets |
5,457,097.11 |
| Other Non-Current Assets |
109,360.69 |
| Sub-Total of Non-Current Assets |
92,724,438.12 |
| Total Assets |
1,369,119,342.01 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
399,823,736.08 |
| Accounts Received In Advance |
362,005.54 |
| Employee Compensation Payable |
13,394,194.01 |
| Taxes Payable |
9,685,600.75 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,822,718.76 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
14,720,716.88 |
| Sub-Total of Current Liabilities |
452,076,350.84 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
6,427,401.19 |
| Total Liabilities |
458,503,752.03 |
| Paid-In Capital(Or Share Stock) |
243,678,373.00 |
| Capital Surplus |
191,498,722.80 |
| Surplus Reserve |
122,518,621.62 |
| LESS:Treasury Stock |
36,399,013.95 |
| Undistributed Profits |
389,318,886.51 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
910,615,589.98 |
| Owner's Equity（Stockholder's Equity） |
910,615,589.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,369,119,342.01 |
